The safety and quality of allograft bio-implants are critical to physicians and their patients. As a leading regenerative medicine company, LifeNet Health has developed a full suite of technologies to ensure these needs are met with every allograft we provide.
This patented and validated process renders allograft bio-implant tissue acellular; without compromising the biomechanical or desired biochemical properties of an allograft bio-impant surgical application.1
Our proprietary, glycerol-based preservation solution allows bio-implants to be stored in a fully hydrated state at ambient temperature.2 This eliminates the need for lengthy rehydration, and saves valuable OR time.
- ALLOWASH XG®
For optimal safety, Allowash XG is a 6 step process which addresses bioburden to provide medical implant level of sterility while maintaining the biomechanical and biochemical properties of our allografts.3-4
- Data on File at LifeNet Health: TR-0082, TR-0119, and TR-0148
- Graham R, et al. Evaluation of Glycerol-Preserved Bone Allografts in Cervical Spine Fusion: A Prospective, Randomized Controlled Trial. J Neurosurg Spine. 2015;22.1: 1-10
- Moore MA. Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell Tissue Bank. 2012 Aug;13(3):401-7. doi: 10.1007/s10561-011-9266-0.
- Data on File at LifeNet Health: TR-0020 & TR-0023